2018 GLDMDG Meeting Announcement

The GLDMDG steering committee would like to thank this year’s attendees for contributing to another successful meeting. We hope to see you next year at our 13th annual meeting in Indianapolis, Indiana on May 10 & 11, 2018.

By | 2017-07-01T22:33:31+00:00 Sunday, 14 May 2017|2018 Meeting|

Online Registration is Closed

Registration for this year’s GLDMDG meeting has closed. No on-site registration will be available.  We look forward to meeting the registered attendees on May 4th & 5th at the Bernhard Center on the campus of Western Michigan University in Kalamazoo, Michigan. The meeting’s schedule and related meeting information can be found in the 2017 Meeting section of this website.

By | 2017-07-01T22:36:25+00:00 Saturday, 22 April 2017|2017 Meeting|

2017 Meeting Schedule

The GLDMDG steering committee is pleased to announce the schedule for this year’s meeting. The meeting will take place on May 4th and 5th at the Bernhard Center on the campus of Western Michigan University in Kalamazoo, Michigan.  Online registration for this meeting will open on Monday, February 20th at 8:00 AM EST.

Thursday, May 4, 2017

Registration, Continental Breakfast, Poster Setup, and Sponsor Booth Setup, 10:00 AM

Welcome, 11:00 AM

P450 Structure-Function Studies at Large Scale: Application to Pharmacogenomics., 11:10 AM
Allan Rettie, Ph.D., Professor, Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle.

Genetic and Functional Studies of Chemotherapy-Induced Peripheral Neuropathy., 11:50 AM
Deanna Kroetz, Ph.D., Professor, Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, University of California, San Francisco.

Lunch, Students and Postdocs Network with Industry Scientists, View Posters, and Visit Sponsor Booths, 12:30 PM

Quantitative Proteomic Analysis for Membrane Proteins in Healthy and Disease Tissues to Delineate Drug Clearance and Intracellular Disposition., 2:00 PM
Yurong Lai, Ph.D., Director of Drug Metabolism, Gilead Sciences, Inc., Foster City, CA.

Transporters in Xeno-Endobiotic Drug Interactions., 2:40 PM
Eve-Irene Lepist, Ph.D., Sr. Research Scientist II, Gilead Sciences, Inc., Foster City, CA.

Break, 3:20 PM

Cytochrome P450 3A7: Fetal Drug Metabolism., 3:40 PM
Emily Scott, Ph.D., Professor, Medicinal Chemistry and Professor, Pharmacology, University of Michigan, Ann Arbor.

Structural Plasticity in Drug Metabolizing P4503A4., 4:20 PM
Tom Poulos, Ph.D., Chancellor’s Professor of Biochemistry, Chemistry, and Pharmaceutical Sciences, University of California, Irvine.

Poster Session (Author Available), Sponsor Booths, and Mixer, 5:00 PM

Dinner, 7:00 PM

Friday, May 5, 2017

GLDMDG Business Meeting and Sponsor Booth Setup, 7:30 AM

Continental Breakfast and Poster Viewing, 7:30 AM

Pharmacologically Active Acyl Glucuronide Metabolites of Indole-3-carboxylic Acid-based AMP Kinase Activators., 9:00 AM
Amit Kalgutkar, Ph.D., Research Fellow at Pfizer and Adjunct Professor, Department of Pharmacy and Biomedical Sciences at the University of Rhode Island.

Gut Microbiome: A Novel Frontier in Xenobiotic Biotransformation., 9:40 AM
Julia Yue Cui, Ph.D., Assistant Professor, Department of Environmental and Occupational Health Sciences and Center for Ecogenetic and Environmental Health, University of Washington, Seattle.

Break, 10:20 AM

Non-CYP Drug Metabolism Pathways and Selected Case Studies., 10:40 AM
David Stresser, Ph.D., Principal Research Scientist, AbbVie, North Chicago, IL.

TBD., 11:20 AM
Student Presentation.

TBD., 11:35 AM
Post-Doc Presentation.

Closing Remarks, 11:50 AM

By | 2017-02-24T12:44:31+00:00 Wednesday, 15 February 2017|2017 Meeting|